Related Experiment Video

Updated: May 14, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Infant meningococcal vaccination: Advisory Committee on Immunization Practices (ACIP) recommendations and rationale

    MMWR. Morbidity and Mortality Weekly Report
    |January 25, 2013
    PubMed

    Insights

    The Advisory Committee on Immunization Practices recommends the Hib-MenCY-TT vaccine for infants at higher risk of meningococcal disease caused by serogroups C and Y. This vaccine protects against Haemophilus influenzae type b and specific meningococcal serogroups.

    Area of Science:

    • Immunology
    • Vaccinology
    • Public Health

    Background:

    • Meningococcal disease poses a significant risk, particularly to infants.
    • Existing vaccines had limitations for infant immunization against specific serogroups.
    • The Advisory Committee on Immunization Practices (ACIP) reviews vaccine recommendations.

    Purpose of the Study:

    • To summarize ACIP's deliberations and rationale for recommending a new vaccine.
    • To provide guidance on the use of Hib-MenCY-TT in at-risk infants.
    • To detail the approved indications for Hib-MenCY-TT.

    Main Methods:

    • Review of ACIP meeting proceedings and vaccine data.
    • Analysis of licensure information for Hib-MenCY-TT and other meningococcal vaccines.
    • Evaluation of disease epidemiology and risk factors.

    Main Results:

    • ACIP recommended Hib-MenCY-TT for infants 6 weeks to 18 months at increased risk for serogroups C and Y meningococcal disease.
    • Hib-MenCY-TT is licensed for protection against Haemophilus influenzae type b and meningococcal serogroups C and Y.
    • It is not indicated for serogroup B, W135, or A, and no prior conjugate vaccine was licensed for infants under 8 months.

    Conclusions:

    • Hib-MenCY-TT provides crucial protection for at-risk infants against specific meningococcal serogroups.
    • The recommendation addresses a gap in infant meningococcal conjugate vaccination.
    • Understanding vaccine indications is vital for effective disease prevention.

    More Related Videos

    Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

    Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

    Published on: May 19, 2020

    Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

    Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

    Published on: February 23, 2014

    Related Concept Videos

    Bacterial Meningitis I: Introduction01:22

    Bacterial Meningitis I: Introduction

    Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
    Bacterial Meningitis II: Pathophysiology01:26

    Bacterial Meningitis II: Pathophysiology

    Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
    Viral Meningitis01:18

    Viral Meningitis

    Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
    Vaccinations01:51

    Vaccinations

    Overview
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    Healthcare Associated Infections II: Preventive Measures01:22

    Healthcare Associated Infections II: Preventive Measures

    Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
    The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...